Liver sinusoidal endothelial cells and fibrosis.

肝窦内皮细胞和纤维化。

基本信息

  • 批准号:
    8898790
  • 负责人:
  • 金额:
    $ 35.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In vitro, liver sinusoidal endothelial cells (LSECs) from healthy liver prevent hepatic stellate cell (HSC) activation and promote inactivation of activated HSC, but LSECs that have "capillarized" do not. Capillarization, the loss of LSEC fenestration and formation of a more organized basement membrane in the space of Disse, precedes fibrosis. In vivo, pharmacological reversal of capillarization after discontinuing a fibrotic insult accelerates inactivation of HSC and regression of fibrosis, whereas reversal of capillarization while a fibrotic stimulus is continued prevents progression of cirrhosis. Thus capillarization doesn't just precede fibrosis, but is permissive for hepatic fibrosis. The goals of this proposal are two-fold. First, examine how LSECs promote HSC quiescence. Second, elucidate the mechanisms that lead to capillarization. This proposal has three specific aims. In specific aim 1 the protein secreted by LSECs that promotes HSC quiescence will be identified, its in vivo activity will be confirmed, expression patterns within the liver will be immunolocalize, and its signaling within HSC will be examined. Specific 2 will examine the genesis of "capillarized" LSECs in a model of toxin-induced fibrosis and confirm that capillarized LSECs in a model of diet-induced non-alcoholic steatohepatitis have the same origin. Integrin expression, endocytosis and endocytosis receptors, and transcriptomic profiling in in vivo capillarized LSECs will be compared with LSECs from normal liver and in vitro capillarized LSECs to better understand capillarization. Preliminary data for specific aim 3 has identified a change within the fibrotic liver associated with loss of LSEC fenestration and with angiogenesis. Specific aim 3 will determine which type of liver cell is responsible for the change; confirm the association with loss of fenestration, HSC activation, fibrosis and angiogenesis; examine signaling pathways in the LSEC; and characterize the regulation of the change in the capillarized liver. Successful completion of these aims will transform our understanding of the mechanisms underlying capillarization and provide potential therapeutic targets to treat fibrosis.
描述(由申请方提供):在体外,来自健康肝脏的肝窦内皮细胞(LSEC)可防止肝星状细胞(HSC)活化并促进活化HSC的失活,但“毛细血管化”的LSEC则不会。毛细血管化,LSEC开窗的丧失和在Disse间隙中形成更有组织的基底膜,先于纤维化。在体内,停止纤维化损伤后的毛细血管化的药理学逆转加速HSC的失活和纤维化的消退,而在纤维化刺激持续的同时毛细血管化的逆转防止肝硬化的进展。因此,毛细血管化不仅先于纤维化,而且是肝纤维化的必要条件。的目标 这项建议有两个方面。首先,研究LSEC如何促进HSC静止。第二,阐明导致毛细作用的机制。这项建议有三个具体目标。在具体目标1中,将鉴定由LSEC分泌的促进HSC静止的蛋白质,将确认其体内活性,将免疫定位肝脏内的表达模式,并将检查其在HSC内的信号传导。特异性2将检查毒素诱导的纤维化模型中“毛细血管化”LSEC的起源,并证实饮食诱导的非酒精性脂肪性肝炎模型中的毛细血管化LSEC具有相同的起源。将在体内毛细化LSEC中的整合素表达、内吞作用和内吞作用受体以及转录组学谱与来自正常肝脏的LSEC和体外毛细化LSEC进行比较,以更好地理解毛细化。具体目标3的初步数据已经确定了与LSEC开窗丢失和血管生成相关的纤维化肝脏内的变化。具体目标3将 确定哪种类型的肝细胞负责的变化;确认与损失的关联 开窗,HSC活化,纤维化和血管生成;检查LSEC中的信号传导通路;并表征毛细血管化肝脏中变化的调节。这些目标的成功实现将改变我们对毛细血管化机制的理解,并为治疗纤维化提供潜在的治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURIE D DELEVE其他文献

LAURIE D DELEVE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURIE D DELEVE', 18)}}的其他基金

Role of Dietary Nutrients in Induction of Pseudocapillarization and the Functional Consequences for Hyperlipidemia
膳食营养素在诱导假性毛细血管化中的作用以及高脂血症的功能性后果
  • 批准号:
    10674261
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
Liver sinusoidal endothelial cells and fibrosis.
肝窦内皮细胞和纤维化。
  • 批准号:
    8756248
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
肝窦内皮细胞祖细胞 (sprocs) 与慢性肝病
  • 批准号:
    9884512
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
肝窦内皮细胞祖细胞 (sprocs) 与慢性肝病
  • 批准号:
    10551832
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
肝窦内皮细胞祖细胞 (sprocs) 与慢性肝病
  • 批准号:
    10319553
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Liver sinusoidal endothelial cells and fibrosis.
肝窦内皮细胞和纤维化。
  • 批准号:
    9115580
  • 财政年份:
    2014
  • 资助金额:
    $ 35.89万
  • 项目类别:
Determinants of sinusoidal endothelial cell phenotype
正弦内皮细胞表型的决定因素
  • 批准号:
    6791369
  • 财政年份:
    2003
  • 资助金额:
    $ 35.89万
  • 项目类别:
Determinants of sinusoidal endothelial cell phenotype
正弦内皮细胞表型的决定因素
  • 批准号:
    7097895
  • 财政年份:
    2003
  • 资助金额:
    $ 35.89万
  • 项目类别:
Determinants of sinusoidal endothelial cell phenotype
正弦内皮细胞表型的决定因素
  • 批准号:
    6936525
  • 财政年份:
    2003
  • 资助金额:
    $ 35.89万
  • 项目类别:
Determinants of Sinusoidal Endothelial Cell Phenotype.
正弦曲线内皮细胞表型的决定因素。
  • 批准号:
    7688618
  • 财政年份:
    2003
  • 资助金额:
    $ 35.89万
  • 项目类别:

相似海外基金

Impact of physical exercise on brain-bone marrow interactions in postmenopausal rats: potential mechanisms preventing menopause-induced hypertension
体育锻炼对绝经后大鼠脑-骨髓相互作用的影响:预防绝经期高血压的潜在机制
  • 批准号:
    24K20609
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Engineering the bone marrow niche to control stem cell regulation, metastatic evolution and cancer dormancy
改造骨髓生态位来控制干细胞调节、转移进化和癌症休眠
  • 批准号:
    EP/X036049/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Research Grant
Understanding the link between bone marrow failure and chronic inflammation through the lens of VEXAS syndrome
从 VEXAS 综合征的角度了解骨髓衰竭与慢性炎症之间的联系
  • 批准号:
    MR/Y011945/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Research Grant
Bone Marrow Adipogenesis in Response to Chemotherapy and Resultant Effect on Bone Metastasis
骨髓脂肪生成对化疗的反应及其对骨转移的影响
  • 批准号:
    491636
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Miscellaneous Programs
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
  • 批准号:
    10537391
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
Mechanisms of Parp inhibitor-induced bone marrow toxicities
Parp 抑制剂诱导骨髓毒性的机制
  • 批准号:
    10637962
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
保护骨髓生态位的完整性和功能,使老化的造血干细胞恢复活力
  • 批准号:
    10735925
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
  • 批准号:
    10761397
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
Selective Radionuclide Delivery for Precise Bone Marrow Niche Alterations
选择性放射性核素输送以实现精确的骨髓生态位改变
  • 批准号:
    10727237
  • 财政年份:
    2023
  • 资助金额:
    $ 35.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了